Reaction
Anisocytosis reporting signals
As of the last recalculation, Anisocytosis appears in 641 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is RIBOCICLIB (PRR 91.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ribociclib | 78 | 91.2 | 91.5 |
| Ampicillin | 13 | 52.0 | 52.1 |
| Ampicillin Sodium | 13 | 52.0 | 52.1 |
| Gentamicin | 20 | 51.2 | 51.3 |
| Gentamicin Sulfate | 20 | 42.4 | 42.4 |
| Fulvestrant | 38 | 39.6 | 39.7 |
| Letrozole | 53 | 30.4 | 30.4 |
| Letrozole Tablets | 37 | 26.4 | 26.5 |
| Valganciclovir Hydrochloride Powder, | 9 | 24.3 | 24.3 |
| Hydroxyurea | 15 | 23.6 | 23.6 |
| Alpelisib | 6 | 22.6 | 22.6 |
| Bendamustine Hydrochloride | 7 | 19.2 | 19.2 |
| Romiplostim | 8 | 17.5 | 17.5 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 5 | 14.8 | 14.8 |
| Gemcitabine | 17 | 14.4 | 14.4 |
| Gemcitabine Hydrochloride | 19 | 12.0 | 12.0 |
| Polatuzumab Vedotin | 3 | 10.0 | 10.0 |